CELLULAR VEHICLES INC.

Biotech · Private

Shear-thinning hydrogel delivery system for encapsulating and delivering cell therapies to solid tissues

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Total capital
$1.3M
Federal grants
$1.3M
2 awards · 2024–2026
Rank in peer group#11 of 18
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
9 pending · first 2022
Rank in peer group#5 of 18

Capital timeline

202420252026FEDERAL ↑EQUITY ↓Cumulative $1.3M$295K$1M
202420252026FEDERAL ↑EQUITY ↓Cumulative $1.3M$295K$1M

Latest events

  • Federal grantHealth and Human S · Phase II · Development of a novel tool that standardizes and automates the formulation of cell-laden hydrogels$1M
  • Federal grantHealth and Human S · Phase I · Development of a novel tool for cell therapies that automates the formation and injection of cell-laden hydrogels directly into tissue$295K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 18 peers

Line = median

Biotech · Material

  • Federal grantsBelow median
  • Granted patents#5 · top 28%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 11
Show all 11 patent records
  • Cellular Therapy Infusion Devices, Systems, And Methods For UseDec 25, 2025 · Application 19256139Pending
  • Cellular Therapy Infusion Devices, Systems, And Methods For UseJul 15, 2025 · US 12,357,772Granted
  • Cellular Therapy Infusion Devices, Systems, And Methods For UseNov 22, 2022 · US 11,504,485Granted
  • Microfluidic Systems And Devices For Suspension Therapy Preparation And/or Infusion And Methods For UseApplication 63574874Pending
  • Systems And Devices For Suspension Therapy Preparation And/or Infusion And Methods For UseApplication PCTUS2023079546Pending
  • Systems And Devices For Preparation And/or Infusion Of Suspension TherapiesApplication 63598046Pending
  • Systems And Devices For Cellular Therapy Preparation And Infusion And Methods For UseApplication 63463818Pending
  • Systems And Devices For Cellular Therapy Preparation And Infusion And Methods For UseApplication 63424862Pending
  • Microfluidic Systems, Devices, And Kits For Suspension Therapy Preparation And/or Infusion And Methods For UseApplication 63645822Pending
  • Cellular Therapy Infusion Devices, Systems, And Methods For UseApplication PCTUS2022040519Pending
  • Microfluidic Systems, Devices, And Kits For Suspension Therapy Preparation And/or Infusion And Methods For UseApplication PCTUS2025023268Pending
  • REGENE LLCSimilar federal contract value in Biotech · null in contracts
  • GAVIA BIO, LLCSimilar federal contract value in Biotech · null in contracts
  • ANEKABIO LLCSimilar federal contract value in Biotech · null in contracts
  • GRUTHAN BIOSCIENCE LLCSimilar federal contract value in Biotech · null in contracts
  • ALZARROK BIO LLCSimilar federal contract value in Biotech · null in contracts
  • CRYSTAL BIOSCIENCE, INC.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .